Holen Sie sich die Stockscreener-App
76.68
0.79%
0.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$76.07
Offen:
$76.84
24-Stunden-Volumen:
2.12M
Relative Volume:
0.25
Marktkapitalisierung:
$97.53B
Einnahmen:
$402.11B
Nettoeinkommen (Verlust:
$1.73B
KGV:
55.42
EPS:
1.3835
Netto-Cashflow:
$7.81B
1W Leistung:
-1.60%
1M Leistung:
-2.30%
6M Leistung:
+2.26%
1J Leistung:
+16.61%
1-Tages-Spanne:
$76.41
$77.17
1-Wochen-Bereich:
$75.32
$78.75
52-Wochen-Spanne:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
76.66 | 96.78B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
UNH
Unitedhealth Group Inc
|
281.44 | 251.47B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CI
Cigna Group
|
266.95 | 70.07B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
292.31 | 63.54B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
165.98 | 19.65B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Landscape Capital Management L.L.C. Raises Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health stock price target kept at $105 by TD Cowen on survey data - Investing.com
CVS Health Corp Stock (ISIN: US1266501006) Gains Momentum on Bernstein Upgrade to Outperform - AD HOC NEWS
CVS Health (CVS) Receives Analyst Upgrade and Raised Price Targe - GuruFocus
Cramer's stop trading: CVS Health - MSN
Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event - Investing.com UK
CVS Stock Upgraded as Analyst Sees Significant Upside - GuruFocus
Bernstein upgrades CVS Health stock rating on reform clarity - Investing.com
CVS Health Corporation $CVS is Watchtower Advisors LP's Largest Position - MarketBeat
Franklin Resources Inc. Sells 453,717 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health launches Health100 AI platform with Google CloudBizwomen - The Business Journals
CVS Health (CVS) Settles $117.7M Medicare Allegations - GuruFocus
Van ECK Associates Corp Has $98.60 Million Holdings in CVS Health Corporation $CVS - MarketBeat
Lab's Aetna Payment Suit Survives, But With Deep Cuts - Law360
A look at how CVS is leaning on 'agentic twins' in developing consumer tech - Fierce Healthcare
Preparing our colleagues for the future of work - CVS Health
$2.24M push aims to cut ER trips for Columbus families on south and east sides - Stock Titan
Capital International Investors Has $2.01 Billion Stock Position in CVS Health Corporation $CVS - MarketBeat
How Investors May Respond To Alphabet (GOOGL) Powering CVS’s Health100 AI Healthcare Platform With Google Cloud - Yahoo Finance
Alphabet Inc. (GOOGL): CVS Health To Roll Out AI-enabled Platform With Google Cloud - Insider Monkey
JPMorgan employees can sue over bank allowing excessive payments to CVS Caremark, says judgereport - Seeking Alpha
CVS Health at Leerink Conference: Strategic Integration Unveiled - Investing.com
Korea Investment CORP Cuts Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by First Trust Advisors LP - MarketBeat
CVS Health Bets On Health100 To Unite AI And Consumer Care - Yahoo Finance
CVS teams up with Google Cloud to launch AI health platform - The Business Journals
IFG Advisory LLC Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS taps Google Cloud to roll out AI-powered health platform By Reuters - Investing.com
CVS Ducks Defunct Hospital’s Federal Drug-Pricing ‘Tying’ Claims - Bloomberg Law News
Leerink reiterates CVS Health stock rating on AI platform launch - Investing.com
CVS Health partners with Google; launching health tech subsidiary - Chain Store Age
CVS Health (CVS) Launches AI-Powered Health100 with Google Cloud - GuruFocus
CVS Health launches AI health platform with Google Cloud - Investing.com
CVS launches Health100 backed by Google Cloud’s AI tech - Seeking Alpha
CVS Health Partners Google Cloud To Transform Healthcare Consumer Engagement - Nasdaq
CVS warns it could close all 134 locations in a single state if new bill goes ahead - Yahoo Finance
CVS taps Google Cloud to roll out AI-powered health platform - Reuters
CVS Health to launch health tech subsidiary, AI platform - Modern Healthcare
CVS and Google Cloud build AI health partner to cut care stress, costs - Stock Titan
Is CVS Health (CVS) Still Attractive After A 27% One Year Share Price Gain - Yahoo Finance
Dimensional Fund Advisors LP Sells 1,064,002 Shares of CVS Health Corporation $CVS - MarketBeat
CVS, Google Cloud partner on healthcare consumer engagement platform - Yahoo Finance
USA Herald - USA Herald
CVS Beats Antitrust Suit Over 340B Drug Program, For Good - Law360
Tennessee Legislation Puts CVS Pharmacy Model And Valuation In Focus - simplywall.st
CVS Pharmacy is quietly changing how you get meds in the US - AD HOC NEWS
Price Over Earnings Overview: CVS Health - Benzinga
Truist Securities reiterates Buy rating on CVS Health stock at $98 - Investing.com South Africa
CVS says 134 Tennessee locations will close if 'conflict of interest' bill passes - KATV
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):